Jean-Marie Eveillard - First Eagle Investment Management,
Holding/activity history for Halozyme Therapeutics (HALO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2020 Q4 | 0 | 0.00 | Sell 100.00% | 0.04 | SEC | ||
| 2020 Q3 | 483,800 | 0.04 | Reduce 68.12% | 0.09 | $26.28 | $12,714,000 | SEC |
| 2020 Q2 | 1,517,627 | 0.13 | Reduce 4.17% | <0.01 | $26.81 | $40,688,000 | SEC |
| 2020 Q1 | 1,583,675 | 0.10 | Reduce 3.23% | <0.01 | $17.99 | $28,490,000 | SEC |
| 2019 Q4 | 1,636,475 | 0.08 | Reduce 0.06% | $17.73 | $29,015,000 | SEC | |
| 2019 Q3 | 1,637,475 | 0.07 | Reduce 3.47% | <0.01 | $15.51 | $25,397,000 | SEC |
| 2019 Q2 | 1,696,275 | 0.08 | Reduce 20.30% | 0.02 | $17.18 | $29,142,000 | SEC |
| 2019 Q1 | 2,128,275 | 0.09 | Reduce 0.12% | <0.01 | $16.10 | $34,265,000 | SEC |
| 2018 Q4 | 2,130,775 | 0.09 | Reduce 1.95% | <0.01 | $14.63 | $31,173,000 | SEC |
| 2018 Q3 | 2,173,089 | 0.10 | Add 2.28% | <0.01 | $18.17 | $39,485,000 | SEC |
| 2018 Q2 | 2,124,563 | 0.09 | Reduce 29.29% | 0.04 | $16.87 | $35,841,000 | SEC |
| 2018 Q1 | 3,004,753 | 0.15 | Reduce 33.69% | 0.07 | $19.59 | $58,863,000 | SEC |
| 2017 Q4 | 4,531,081 | 0.22 | Reduce 29.70% | 0.07 | $20.26 | $91,800,000 | SEC |
| 2017 Q3 | 6,444,981 | 0.25 | Reduce 12.84% | 0.03 | $17.37 | $111,949,000 | SEC |
| 2017 Q2 | 7,394,315 | 0.23 | $12.82 | $94,795,000 | SEC | ||
| 2017 Q1 | 7,394,315 | 0.24 | Reduce 3.81% | <0.01 | $12.96 | $95,830,000 | SEC |
| 2016 Q4 | 7,687,515 | 0.19 | Add 3.95% | <0.01 | $9.88 | $75,953,000 | SEC |
| 2016 Q3 | 7,395,500 | 0.23 | Add 4.15% | <0.01 | $12.08 | $89,338,000 | SEC |
| 2016 Q2 | 7,101,000 | 0.16 | Add 6.56% | <0.01 | $8.63 | $61,282,000 | SEC |
| 2016 Q1 | 6,663,700 | 0.16 | Add 54.76% | 0.06 | $9.47 | $63,105,000 | SEC |
| 2015 Q4 | 4,305,900 | 0.19 | Add 6.10% | 0.01 | $17.33 | $74,621,000 | SEC |
| 2015 Q3 | 4,058,500 | 0.14 | Reduce 2.49% | <0.01 | $13.43 | $54,506,000 | SEC |
| 2015 Q2 | 4,162,000 | 0.23 | Add 8.55% | 0.02 | $22.58 | $93,978,000 | SEC |
| 2015 Q1 | 3,834,050 | 0.13 | Reduce 3.92% | <0.01 | $14.28 | $54,750,000 | SEC |
| 2014 Q4 | 3,990,480 | 0.10 | Add 9.61% | <0.01 | $9.65 | $38,508,000 | SEC |
| 2014 Q3 | 3,640,480 | 0.09 | Add 30.25% | 0.02 | $9.10 | $33,128,000 | SEC |
| 2014 Q2 | 2,795,080 | 0.07 | Add 94.94% | 0.03 | $9.88 | $27,615,000 | SEC |
| 2014 Q1 | 1,433,780 | 0.05 | Add 10.75% | <0.01 | $12.70 | $18,209,000 | SEC |
| 2013 Q4 | 1,294,580 | 0.06 | Buy | 0.06 | $14.99 | $19,406,000 | SEC |